Diagnose Your Portfolio’s Factor DNA
Free tools can estimate exposure to market, size, value, momentum, profitability, and investment. Even a rough regression on historical returns can reveal hidden tilts. You don’t need perfection—directional clarity is enough to guide sensible decisions.
Diagnose Your Portfolio’s Factor DNA
Fund names can mislead. Scan methodology documents, sector caps, turnover, and reconstitution rules. A value ETF heavy in tech with minimal rebalancing might behave differently than expected. Ask for a walkthrough of your fund’s fact sheet in the comments.